Values as of: 2024-06-26
EQUITY | Specialty Chemicals | New York Stock Exchange
Last Closing
USD 81.84Change
+0.08 (+0.10)%Market Cap
USD 1.78BVolume
0.14MVerdict
Verdict
Stepan Co, along with its subsidiaries produces specialty and intermediate chemicals, which are sold to other manufacturers and are used in end products. The Company manufactures & markets surfactants, polymers and specialty products.
Company Website : http://www.stepan.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SHW | Sherwin-Williams Co |
N/A |
USD 76.38B |
| ECL | Ecolab Inc |
N/A |
USD 69.68B |
| APD | Air Products and Chemicals Inc |
N/A |
USD 59.38B |
| DD | Dupont De Nemours Inc |
N/A |
USD 33.62B |
| LYB | LyondellBasell Industries NV |
N/A |
USD 31.19B |
| PPG | PPG Industries Inc |
N/A |
USD 29.37B |
| DLY | DoubleLine Yield Opportunities.. |
N/A |
USD 27.84B |
| IFF | International Flavors & Fragra.. |
N/A |
USD 24.51B |
| WLK | Westlake Chemical Corporation |
N/A |
USD 19.02B |
| AVTR | Avantor Inc |
N/A |
USD 15.28B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| EUDIV:PA | Lyxor S&P Eurozone ESG Di.. | 4.47 % | 0.00 % |
N/A |
N/A |
| ZPD9:XETRA | SPDR® S&P® Euro Dividen.. | 4.44 % | 0.00 % |
N/A |
USD 6.13M |
| FEUZ | First Trust Eurozone Alph.. | 1.27 % | 0.80 % |
N/A |
USD 0.02B |
| FEUZ:LSE | First Trust Eurozone Alph.. | 0.00 % | 0.00 % |
N/A |
USD 0.06B |
| FEUD:LSE | First Trust Eurozone Alph.. | 0.00 % | 0.00 % |
N/A |
USD 0.09B |
| FTEU:LSE | First Trust Eurozone Alph.. | 0.00 % | 0.00 % |
N/A |
USD 0.07B |
| Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange (New York Stock Exchange) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -13.44% | 24% | F | 14% | F | ||
| Dividend Return | 0.79% | 41% | F | 25% | F | ||
| Total Return | -12.65% | 22% | F | 13% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -12.52% | 28% | F | 16% | F | ||
| Dividend Return | 1.59% | 38% | F | 24% | F | ||
| Total Return | -10.92% | 24% | F | 16% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -10.96% | 30% | F | 35% | F | ||
| Dividend Return | 7.07% | 27% | F | 24% | F | ||
| Total Return | -3.89% | 24% | F | 26% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -0.82% | 28% | F | 35% | F | ||
| Dividend Return | 0.39% | 26% | F | 31% | F | ||
| Total Return | 1.21% | 36% | F | 29% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 19.55% | 85% | B | 53% | F | ||
| Risk Adjusted Return | 1.98% | 24% | F | 30% | F | ||
| Market Capitalization | 1.78B | 39% | F | 64% | D | ||
| Ratio vs. Industry/Classification (Specialty Chemicals) | Ratio vs. Market (New York Stock Exchange) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| Market Value | |||||||
| Price / Earning Ratio | 20.20 | 11% | 11% | ||||
| Price/Book Ratio | 1.55 | 64% | 51% | ||||
| Price / Cash Flow Ratio | 10.81 | 45% | 35% | ||||
| Price/Free Cash Flow Ratio | 14.57 | 24% | 26% | ||||
| Management Effectiveness | |||||||
| Return on Equity | 3.16% | 27% | 35% | ||||
| Return on Invested Capital | 3.56% | 24% | 37% | ||||
| Return on Assets | 1.86% | 22% | 42% | ||||
| Debt to Equity Ratio | 32.98% | 85% | 71% | ||||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
